Last reviewed · How we verify
NCT04795635
Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management
NA trial testing CMM + Axon Therapy in Neuropathic Pain in 61 participants. Participants enrolled and being followed up; not accepting new ones.
22 May 2024
Quick facts
| Lead sponsor | NeuraLace Medical, Inc. |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 61 |
| Start date | 14 April 2021 |
| Primary completion | 22 May 2024 |
| Estimated completion | 22 August 2024 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- CMM + Axon Therapy
Conditions studied
- Neuropathic Pain — all drugs for Neuropathic Pain →
- Peripheral Neuropathy — all drugs for Peripheral Neuropathy →
Sponsor
NeuraLace Medical, Inc.
Who can join
Adults 18 to 75, any sex, with Neuropathic Pain or Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Compare Axon Therapy using transcutaneous magnetic stimulation (tMS) against conventional medical management in treating post-traumatic peripheral neuropathic pain (PTPNP).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Safety and Efficacy of Axon Therapy (SEAT Study), Utilizing Magnetic Peripheral Nerve Stimulation (mPNS) for Treatment of Neuropathic Pain.
Kapural L, Patel J, Rosenberg JC, Li S, et al · · 2024 · cited 5× · PMID 39359387 · DOI 10.2147/jpr.s481944 -
Efficacy and Safety of Magnetic Peripheral Nerve Stimulation for Treatment of Neuropathic Pain; One Year Follow Up of Long-Term Outcomes.
Kapural L, Patel J, Rosenberg JC, Li S, et al · · 2025 · PMID 40918409 · DOI 10.2147/jpr.s538263
Verify or expand the search:
- PubMed search for NCT04795635
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neuropathic Pain
Currently open trials in the same condition.
- NCT07493213 — USG-Guided Shoulder Injections in Frozen Shoulder · NA · recruiting
- NCT07493226 — Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis · NA · recruiting
- NCT06398847 — Virtual Reality (VR) Self-Hypnosis Software · NA · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07436806 — SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery · NA · recruiting
Other NeuraLace Medical, Inc. trials
Trials by the same sponsor.
- NCT05935956 — Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy · completed
- NCT05620225 — Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medic · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04795635 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NeuraLace Medical, Inc.
- Last refreshed: 12 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04795635.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing